These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39047534)

  • 1. Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012-2021).
    de Nijs K; de Koning HJ; van der Aalst C; Ten Haaf K
    Eur J Cancer; 2024 Sep; 208():114231. PubMed ID: 39047534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
    Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
    Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.
    Zeng X; Karnon J; Wang S; Wu B; Wan X; Peng L
    PLoS One; 2012; 7(10):e48323. PubMed ID: 23118985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.
    Tramontano AC; Chen Y; Watson TR; Eckel A; Hur C; Kong CY
    Cancer Med; 2019 Sep; 8(11):5158-5172. PubMed ID: 31347306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
    Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
    Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
    Thein HH; Jembere N; Thavorn K; Chan KKW; Coyte PC; de Oliveira C; Hur C; Earle CC
    BMC Cancer; 2018 Jun; 18(1):694. PubMed ID: 29945563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing costs of metastatic non small cell lung cancer in the Netherlands.
    Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
    Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
    van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
    Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
    Wood R; Taylor-Stokes G
    BMC Cancer; 2019 Mar; 19(1):214. PubMed ID: 30849964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model.
    Buja A; Rivera M; De Polo A; Brino ED; Marchetti M; Scioni M; Pasello G; Bortolami A; Rebba V; Schiavon M; Calabrese F; Mandoliti G; Baldo V; Conte P
    Thorac Cancer; 2021 Jan; 12(1):13-20. PubMed ID: 33219738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of non-small cell lung cancer in the Netherlands.
    van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
    Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
    Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
    J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
    Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
    BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
    Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
    Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First data on direct costs of lung cancer management in Morocco.
    Tachfouti N; Belkacemi Y; Raherison C; Bekkali R; Benider A; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(4):1547-51. PubMed ID: 22799364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System.
    Criss SD; Mooradian MJ; Sheehan DF; Zubiri L; Lumish MA; Gainor JF; Reynolds KL; Kong CY
    JAMA Oncol; 2019 Mar; 5(3):358-365. PubMed ID: 30543349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.